Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities

被引:18
作者
Hang, Hualian [1 ]
Jeong, Seogsong [1 ]
Sha, Meng [1 ]
Kong, Defu [1 ]
Xi, Zhifeng [1 ]
Tong, Ying [1 ]
Xia, Qiang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Liver Surg, Renji Hosp, Sch Med, 160 Pujian Rd, Shanghai 200127, Peoples R China
基金
中国国家自然科学基金;
关键词
Biliary malignancy; bile duct cancer; distal cholangiocarcinoma (dCCA); intrahepatic cholangiocarcinoma (iCCA); perihilar cholangiocarcinoma (hiCCA); DIAGNOSIS;
D O I
10.21037/atm.2019.12.37
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Anatomical location is considered in diagnostic and therapeutic approaches of cholangiocarcinoma (CCA). However, disparities and its extents in proportion of surgical candidates, prognostic factors, prognostic genetic networks, susceptibility for lymph node dissection, and disease stage at diagnosis remain to be confirmed. Methods: A total of 11,710 patients with cholangiocarcinoma from Surveillance, Epidemiology, and End Results Cancer Registries (SEER) and 45 CCA patients with paired tumor and normal specimens from The Cancer Genome Atlas were studied. Kaplan-Meier estimation, Cox proportional hazards regression, Pearson's correlation, comparison between anatomical location (distal, intrahepatic, and perihilar)-dependent CCAs, differential expressive gene stratification, potential interactive gene identification, and confirmation on pathways of the prognostic networks were carried out. Results: Survival outcomes were most favorable in the distal type, followed by perihilar and intrahepatic types, but postsurgical prognosis was slightly higher in intrahepatic type compared to perihilar type. Distant historic stage at diagnosis was noticed in intrahepatic type. Significant prognostic factors and their hazards ratios were dependent to the anatomical location. In addition, lymph node dissection provided significant survival benefits in perihilar type only. Furthermore, prognosis-predictive genes, as well as potential processes and pathways, were significantly among the anatomical location-dependent types that the genes barely overlapped. Conclusions: There are disparities in almost all aspects among distal, intrahepatic, and perihilar CCAs. Anatomical location needs to be considered in treatment, prognostic estimation, identifying targets, and developing therapeutic approaches for CCA.
引用
收藏
页数:17
相关论文
共 27 条
[1]   Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) [J].
Banales, Jesus M. ;
Cardinale, Vincenzo ;
Carpino, Guido ;
Marzioni, Marco ;
Andersen, JesperB. ;
Invernizzi, Pietro ;
Lind, Guro E. ;
Folseraas, Trine ;
Forbes, Stuart J. ;
Fouassier, Laura ;
Geier, Andreas ;
Calvisi, Diego F. ;
Mertens, Joachim C. ;
Trauner, Michael ;
Benedetti, Antonio ;
Maroni, Luca ;
Vaquero, Javier ;
Macias, Rocio I. R. ;
Raggi, Chiara ;
Perugorria, Maria J. ;
Gaudio, Eugenio ;
Boberg, Kirsten M. ;
Marin, Jose J. G. ;
Alvaro, Domenico .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2016, 13 (05) :261-280
[2]   A novel three-miRNA signature predicts survival in cholangiocarcinoma based on RNA-Seq data [J].
Cao, Junyu ;
Sun, Liankang ;
Li, Jie ;
Zhou, Cancan ;
Cheng, Liang ;
Chen, Ke ;
Yan, Bin ;
Qian, Weikun ;
Ma, Qingyong ;
Duan, Wanxing .
ONCOLOGY REPORTS, 2018, 40 (03) :1422-1434
[3]   70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer [J].
Cardoso, F. ;
van't Veer, L. J. ;
Bogaerts, J. ;
Slaets, L. ;
Viale, G. ;
Delaloge, S. ;
Pierga, J. -Y. ;
Brain, E. ;
Causeret, S. ;
DeLorenzi, M. ;
Glas, A. M. ;
Golfinopoulos, V. ;
Goulioti, T. ;
Knox, S. ;
Matos, E. ;
Meulemans, B. ;
Neijenhuis, P. A. ;
Nitz, U. ;
Passalacqua, R. ;
Ravdin, P. ;
Rubio, I. T. ;
Saghatchian, M. ;
Smilde, T. J. ;
Sotiriou, C. ;
Stork, L. ;
Straehle, C. ;
Thomas, G. ;
Thompson, A. M. ;
van der Hoeven, J. M. ;
Vuylsteke, P. ;
Bernards, R. ;
Tryfonidis, K. ;
Rutgers, E. ;
Piccart, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08) :717-729
[4]   Current status of liver transplantation for cholangiocarcinoma [J].
Goldaracena, Nicolas ;
Gorgen, Andre ;
Sapisochin, Gonzalo .
LIVER TRANSPLANTATION, 2018, 24 (02) :294-303
[5]   The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma [J].
Howell, Matthew ;
Valle, Juan W. .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2015, 29 (02) :333-343
[6]   Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma [J].
Ilyas, Sumera I. ;
Gores, Gregory J. .
GASTROENTEROLOGY, 2013, 145 (06) :1215-1229
[7]   Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update [J].
Khan, Shahid A. ;
Davidson, Brian R. ;
Goldin, Robert D. ;
Heaton, Nigel ;
Karani, John ;
Pereira, Stephen P. ;
Rosenberg, William M. C. ;
Tait, Paul ;
Taylor-Robinson, Simon D. ;
Thillainayagam, Andrew V. ;
Thomas, Howard C. ;
Wasan, Harpreet .
GUT, 2012, 61 (12) :1657-1669
[8]   Epidemiology and Risk Factors of Cholangiocarcinoma [J].
Kirstein, Martha M. ;
Vogel, Arndt .
VISCERAL MEDICINE, 2016, 32 (06) :395-400
[9]   Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin [J].
Komuta, Mina ;
Spee, Bart ;
Borght, Sara Vander ;
De Vos, Rita ;
Verslype, Chris ;
Aerts, Raymond ;
Yano, Hirohisa ;
Suzuki, Tetsuya ;
Matsuda, Masanori ;
Fujii, Hideki ;
Desmet, Valeer J. ;
Kojiro, Masamichi ;
Roskams, Tania .
HEPATOLOGY, 2008, 47 (05) :1544-1556
[10]   Molecular Pathogenesis of Cholangiocarcinoma [J].
Labib, Peter L. ;
Goodchild, George ;
Pereira, Stephen P. .
BMC CANCER, 2019, 19 (1)